NCT01591967

Brief Summary

The purpose of this randomized controlled trial (RCT) is to measure the effects of specific thoracic (T5 to T1) chiropractic adjustments on BP and PR in a larger sample size of both normotensive and hypertensive humans.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
290

participants targeted

Target at P75+ for phase_1 hypertension

Timeline
Completed

Started Jan 2010

Shorter than P25 for phase_1 hypertension

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2010

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

April 30, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 4, 2012

Completed
Last Updated

May 4, 2012

Status Verified

May 1, 2012

Enrollment Period

1 month

First QC Date

April 30, 2012

Last Update Submit

May 2, 2012

Conditions

Keywords

ChiropracticBlood pressurePulse RateThoracic

Outcome Measures

Primary Outcomes (1)

  • The purpose of this randomized controlled trial (RCT) was to measure the effects of specific thoracic (T5 to T1) chiropractic adjustments on BP and PR in a larger sample size of both normotensive and hypertensive humans.

    OBJECTIVE: Previous studies on the effects of chiropractic treatment on blood pressure (BP) and pulse rate (PR) have reported decreases in both systolic and diastolic BP, as well as PR. However, many of those studies have been criticized for various study flaws, and accused of drawing erroneous conclusions, due to small sample size and various methodological concerns. The purpose of this randomized controlled trial (RCT) was to measure the effects of specific thoracic (T5 to T1) chiropractic adjustments on BP and PR in a larger sample size of both normotensive and hypertensive humans.

    Baseline, pre-adjustment, post-adjustment

Study Arms (3)

Control

NO INTERVENTION

Control -- no intervention

Placebo w/ sham

NO INTERVENTION

Sham intervention with the adjusting tool turned "off"

Activator treatment

EXPERIMENTAL

Treatment with Activator

Device: Activator IV Adjusting Instrument

Interventions

Activator (http://www.activator.com/products-page/) adjustment effects on BP and PR

Also known as: Activator adjusting instrument, http://www.activator.com/products-page/
Activator treatment

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects were invited to participate in accordance with the Guidelines for Chiropractic Quality Assurance and Practice Parameters: proceedings of the Mercy Center Consensus Conference, Gaithersburg, MD, 1993, Aspen Publishers Inc.
  • Additionally and specifically for this RCT:
  • Both male and female subjects age 18 years and older were invited to participate
  • Subjects must not be pregnant
  • Subjects must not have any recent or current fractures of the arms or legs
  • Subjects must not have any visceral or abdominal condition such that being in the prone position would be detrimental to their health
  • Subjects must not have any known primary cancers of the spine or spinal column, nor any secondary metastatic process of the spine or spinal column
  • Subjects must not be under the influence of drugs or alcohol
  • Subjects must not have vertigo or any other imbalance condition
  • Subjects must not have any arm or leg prosthetic device
  • Subjects must be able to understand spoken and/or written Spanish and/or English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Steven D. Roffers, DC

    Spinal Missions, Inc., LLC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Research

Study Record Dates

First Submitted

April 30, 2012

First Posted

May 4, 2012

Study Start

January 1, 2010

Primary Completion

February 1, 2010

Study Completion

March 1, 2010

Last Updated

May 4, 2012

Record last verified: 2012-05